DNA 나노기술 시장 : 유형별, 용도별, 최종사용자별, 지역별

Global DNA Nanotechnology Market is estimated to be valued at USD 4.4 Bn in 2025 and is expected to reach USD 21.23 Bn by 2032, growing at a compound annual growth rate (CAGR) of 25.2% from 2025 to 2032.

Figure. Global DNA Nanotechnology Market Share (%), By Region 2025

DNA nanotechnology is an emerging field that utilizes the unique properties of DNA to engineer novel arrangements of DNA, and manipulate materials at the nanoscale level. By exploiting the highly specific binding properties of DNA base pairs, DNA nanotechnology allows scientists to construct dynamic devices and structures from DNA and other materials. DNA nanotechnology holds significant promise for applications across various industries, including healthcare, electronics, and materials. It enables the development of programmable and addressable nanoscale structures, devices, and systems through the molecular recognition and self-assembly capabilities of DNA and other nucleic acids. Advances in DNA origami techniques now allow researchers to fold long single strands of DNA into predefined two-dimensional and three-dimensional shapes at the nanoscale. Continued progress in DNA nanotechnology is poised to revolutionize fields such as drug delivery, synthetic biology, nanoelectronics, and more.

Market Dynamics:

Drivers such as the growing focus on nanotechnology-based diagnostic techniques, rising investments in the development of targeted drug delivery methods, and increasing adoption of DNA nanotechnology for various applications are fueling the growth of the DNA nanotechnology market. However, high costs associated with DNA nanotechnology research and technical limitations related to DNA origami fabrication are expected to restrain the market growth. Meanwhile, emerging opportunities lie in the application of DNA nanotechnology in material science for developing functional materials with unique properties. Advances in automated DNA origami design, modeling, and fabrication also hold promise to help address existing challenges and further stimulate market growth in the coming years.

DNA nanotechnology utilizes the molecular recognition properties of DNA and other nucleic acids to create complex, programmable structures at the nanoscale. DNA nanotechnology can be used to develop highly sensitive biosensors for the detection of biomarkers associated with various diseases, improving diagnostic capabilities. DNA nanostructures can be designed to carry and release drug molecules in a controlled manner, targeting specific cells or tissues, which has implications for cancer therapy, among other diseases. DNA-based nanostructures can serve as precise imaging agents, enhancing the resolution and specificity of imaging techniques. Beyond drug delivery, DNA nanotechnology may enable gene regulation therapies and the construction of nano-scale devices that can interact with biological systems for therapeutic purposes. DNA has the potential to revolutionize computing by providing a medium for high-density data storage and the development of biological computing systems. DNA nanotechnology is being used to create novel materials with programmable functions and properties, impacting industries from electronics to biotechnology

For instance, in September 2024, RNA Institute in the College of Arts and Sciences, a research institute, received US$1.9 million from the National Institute of General Medical Sciences, a branch of the National Institutes of Health, to support research exploring ways to exploit DNA nanotechnology for biomedical and materials science applications.

Key features of the study:

• This report provides in-depth analysis of the global DNA nanotechnology market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global DNA nanotechnology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include NuProbe, GATTAQUANT GMBH, Genisphere LLC, INOVIO Pharmaceuticals., tilibit nanosystems, Aummune Therapeutics Ltd., Nanovery, Esya Labs, Nomic, Torus Biosystems, Parabon NanoLabs, Inc., NanoApps Medical Inc., FOx BIOSYSTEMS, Nanion Technologies GmbH, Mehr Mabna Darou, Inc., Nanowerk
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global DNA nanotechnology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global DNA nanotechnology market

Detailed Segmentation:

• By Type:
  • Structural DNA Nanotechnology
  • Extended Lattices
  • Discrete Structures
  • Template Assembly
  • Dynamic DNA Nanotechnology
  • Nanomechanical Devices
  • Strand Displacement Cascades
• By Application:
  • Targeted Drug Delivery
  • Smart Pills
  • Nanolithography
  • Others
• By End User:
  • Biotechnology & Pharmaceutical Companies
  • Academic & Research Institutions
  • Others
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles
  • GATTAQUANT GMBH
  • Genisphere LLC
  • INOVIO Pharmaceuticals.
  • tilibit nanosystems
  • Aummune Therapeutics Ltd.
  • Nanovery
  • Esya Labs
  • Nomic
  • Torus Biosystems
  • Parabon NanoLabs, Inc.
  • NanoApps Medical Inc.
  • FOx BIOSYSTEMS
  • Nanion Technologies GmbH
  • Mehr Mabna Darou, Inc.
  • Nanowerk

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • DNA Nanotechnology Market, By Type
  • DNA Nanotechnology Market, By Application
  • DNA Nanotechnology Market, By End User
  • DNA Nanotechnology Market, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Driver
• Advancing genomics and proteomics research
• Advancements in material science and engineering
• Growing interest from the medical industry
• Growth in the field of nanotechnology
• Restraints
• Market Opportunity
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global DNA Nanotechnology Market, By Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Structural DNA Nanotechnology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Extended Lattices
• Discrete Structures
• Template Assembly
• Dynamic DNA Nanotechnology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Nanomechanical Devices
• Strand Displacement Cascades

6. Global DNA Nanotechnology Market, By Application, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Targeted Drug Delivery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Smart Pills
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Nanolithography
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global DNA Nanotechnology Market, By End User, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Biotechnology & Pharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Academic & Research Institutions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global DNA Nanotechnology Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Country, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Country 2021 -2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
    • South Africa
    • North Africa
    • Central Africa

9. Competitive Landscape

• NuProbe
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GATTAQUANT GMBH
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Genisphere LLC
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• INOVIO Pharmaceuticals.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• tilibit nanosystems
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Aummune Therapeutics Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Nanovery
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Esya Labs
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Nomic
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Torus Biosystems
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Parabon NanoLabs, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• NanoApps Medical Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• FOx BIOSYSTEMS
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Nanion Technologies GmbH
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Mehr Mabna Darou, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Nanowerk
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us